Form 4 Tracker
Travere Therapeutics, Inc.
TVTX

37 insider filings · Latest: May 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 1, 2026Apr 2 9:55 PMElizabeth E ReedChief Legal Officer and GC
Sale
10,000$30.00$300.0K105,211(D)

View →

Apr 1, 2026Apr 1 8:13 PMDube Eric M
Proposed Sale
60,000$30.93$1.9M

View →

Apr 1, 2026Apr 1 8:06 PMELIZABETH REED
Proposed Sale
10,000$30.00$300.0K

View →

Mar 16, 2026Mar 18 8:05 PMElizabeth E ReedChief Legal Officer and GC
Sale
10,000$28.09$280.9K105,211(D)

View →

Mar 16, 2026Mar 16 8:20 PMELIZABETH REED
Proposed Sale
10,000$28.09$280.9K

View →

Feb 20, 2026Feb 24 9:05 PMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Sale
60,000$30.10$1.8M432,886(D)

View →

Feb 20, 2026Feb 20 9:49 PMDube Eric M
Proposed Sale
60,000$30.10$1.8M

View →

Feb 17, 2026Feb 19 9:10 PMElizabeth E ReedChief Legal Officer and GC
Sale
10,000$27.83$278.3K105,211(D)

View →

Feb 17, 2026Feb 17 9:30 PMELIZABETH REED
Proposed Sale
10,000$27.83$278.3K

View →

Feb 4, 2026Feb 5 9:05 PMJula InrigCHIEF MEDICAL OFFICER
Sale
1,779$32.21$57.3K105,706(D)

View →

Feb 4, 2026Feb 5 9:05 PMChristopher R. ClineCHIEF FINANCIAL OFFICER
Sale
1,745$32.19$56.2K111,226(D)

View →

Feb 4, 2026Feb 5 9:05 PMElizabeth E ReedChief Legal Officer and GC
Sale
2,994$32.18$96.4K105,211(D)

View →

Feb 4, 2026Feb 4 9:07 PMELIZABETH REED
Proposed Sale
2,994$32.18$96.4K

View →

Feb 4, 2026Feb 4 9:06 PMJULA INRIG
Proposed Sale
1,779$32.21$57.3K

View →

Feb 4, 2026Feb 4 9:01 PMCHRISTOPHER CLINE
Proposed Sale
1,745$32.19$56.2K

View →

Feb 3, 2026Feb 4 11:00 AMPeter Heerma
Proposed Sale
7,310$32.12$234.8K

View →

Feb 3, 2026Feb 4 2:59 AMElizabeth E. Reed
Proposed Sale
7,175$32.12$230.5K

View →

Feb 3, 2026Feb 4 2:58 AMSandra Calvin
Proposed Sale
4,333$32.12$139.2K

View →

Feb 3, 2026Feb 4 2:45 AMChristopher Cline
Proposed Sale
7,242$32.12$232.6K

View →

Feb 3, 2026Feb 4 2:37 AMJula Inrig
Proposed Sale
6,956$32.12$223.4K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 1, 2026Apr 2 9:55 PMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
60,000$15.460(D)

View →

Apr 1, 2026Apr 2 9:55 PMElizabeth E ReedChief Legal Officer and GC
Option Exercise
10,000$15.4645,000(D)

View →

Mar 16, 2026Mar 18 8:05 PMElizabeth E ReedChief Legal Officer and GC
Option Exercise
10,000$19.0810,000(D)

View →

Feb 20, 2026Feb 24 9:05 PMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
60,000$15.4660,000(D)

View →

Feb 17, 2026Feb 19 9:10 PMElizabeth E ReedChief Legal Officer and GC
Option Exercise
10,000$19.0820,000(D)

View →

Jan 31, 2026Feb 4 2:30 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Grant/Award
303,600$33.10303,600(D)

View →

Jan 31, 2026Feb 4 2:30 AMJula InrigCHIEF MEDICAL OFFICER
Grant/Award
75,000$33.1075,000(D)

View →

Jan 31, 2026Feb 4 2:30 AMChristopher R. ClineCHIEF FINANCIAL OFFICER
Grant/Award
75,000$33.1075,000(D)

View →

Jan 31, 2026Feb 4 2:30 AMPeter HeermaCHIEF COMMERCIAL OFFICER
Grant/Award
69,640$33.1069,640(D)

View →

Jan 31, 2026Feb 4 2:30 AMWilliam E. RoteChief Research Officer
Grant/Award
53,570$33.1053,570(D)

View →

Jan 31, 2026Feb 4 2:30 AMSandra CalvinSVP, CHIEF ACCOUNTING OFFICER
Grant/Award
20,160$33.1020,160(D)

View →

Jan 31, 2026Feb 4 2:30 AMElizabeth E ReedChief Legal Officer and GC
Grant/Award
66,960$33.1066,960(D)

View →

Jan 27, 2026Jan 28 1:25 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
51,865$15.46120,000(D)

View →

Jan 23, 2026Jan 28 1:25 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
8,135$15.46171,865(D)

View →

Jan 20, 2026Jan 21 9:05 PMElizabeth E ReedChief Legal Officer and GC
Option Exercise
10,000$19.0830,000(D)

View →

← Previous

Page 2 of 2